Amphastar Pharmaceuticals Inc. AMPH
$20.02
▼ -2.14% 24H
About
Amphastar Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development, manufacturing, and marketing of generic and proprietary injectable, intranasal, and inhalation products. Its portfolio includes technically challenging medications such as BAQSIMI, the leading prescribed nasal spray glucagon …
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees1,976
TickerAMPH
Statistics
Market Cap$893.6M
Revenue (TTM)$719.9M
Net Income$98.1M
Net Margin13.6%
EPS$2.03
P/E12.37
P/S1.26
P/B1.18
EV/EBITDA6.59
ROE10.4%
Dividend Yield—
Price$20.02
Data: Twelve Data · Revenue = mcap / P/S